Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "UK"

853 News Found

Wockhardt and Serum Life Sciences UK partner to manufacture multiple vaccines in UK
Biotech | March 21, 2022

Wockhardt and Serum Life Sciences UK partner to manufacture multiple vaccines in UK

The facility will produce 150 million vaccine doses per year


Daiichi Sankyo commits US $1 million humanitarian aid to Ukraine
Sustainability | March 11, 2022

Daiichi Sankyo commits US $1 million humanitarian aid to Ukraine

The money will be donated to the United Nations Children’s Fund (UNICEF)


Known Medicine partners with Duke University to predict lung cancer response to drug treatments
Biotech | March 04, 2022

Known Medicine partners with Duke University to predict lung cancer response to drug treatments

Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer


Amneal enters U.S. biosimilars market with approval of Releukotm
Drug Approval | March 02, 2022

Amneal enters U.S. biosimilars market with approval of Releukotm

First of three Amneal biosimilars expected for U.S. approval and launch in 2022


South Korea's OCI acquires 11% stake in Bukwang Pharmaceutical
Biotech | March 01, 2022

South Korea's OCI acquires 11% stake in Bukwang Pharmaceutical

Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical


Novavax UK Phase 3 trial demonstrates protection from Covid-19 over six-month period
Biotech | March 01, 2022

Novavax UK Phase 3 trial demonstrates protection from Covid-19 over six-month period

High level of vaccine efficacy maintained over a 6-month period of surveillance


Bruker releases CCS-Enabled TIMScore and TIMS DIA-NN 4D Proteomics Software
Biotech | March 01, 2022

Bruker releases CCS-Enabled TIMScore and TIMS DIA-NN 4D Proteomics Software

Innovative TIMScore for dda-PASEF and dia-PASEF libraries, combined with TIMS DIA-NN identifies 9000 protein groups from 200 ng K562 lysate in just 35 min gradient


UK Vaccine Network funding for ConserV pan-coronavirus project
News | February 25, 2022

UK Vaccine Network funding for ConserV pan-coronavirus project

UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2


UK MHRA approves Marksans  All in One oral solution
Drug Approval | February 22, 2022

UK MHRA approves Marksans All in One oral solution

Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs


Poxel’s PXL065 granted FDA fast track designation for X-linked adrenoleukodystrophy
Drug Approval | February 20, 2022

Poxel’s PXL065 granted FDA fast track designation for X-linked adrenoleukodystrophy

Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear